Factor Xa inhibitors (Roche/BMS/Aventis)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameFactor Xa inhibitors (Roche/BMS/Aventis)
Drug Alias NameFactor Xa inhibitors (Roche/BMS/RPR)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor IIa inhibitorsFactor Xa inhibitors
TargetsProthrombinCoagulation factor X
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche LtdBristol-Myers Squibb CompanyRhone Poulenc Rorer Sa
Active IndicationsN/A
Inactive IndicationsThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A